Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Ann Clin Transl Neurol. 2023 Apr;10(4):568-578. doi: 10.1002/acn3.51744. Epub 2023 Feb 17.
Frontotemporal dementia (FTD) encompasses a spectrum of neurodegenerative disorders, including behavioural variant FTD (bvFTD), semantic variant primary progressive aphasia (svPPA) and non-fluent variant PPA (nfvPPA). While a strong genetic component is implicated in FTD, genetic FTD in Asia is less frequently reported. We aimed to investigate the frequency of Southeast Asian FTD patients harbouring known genetic FTD variants.
A total of 60 FTD-spectrum patients (25 familial and 35 sporadic) from Singapore and the Philippines were included. All underwent next-generation sequencing and repeat-primed PCR for C9orf72 expansion testing. Neurofilament light chain (NfL) levels were measured in a subset of patients.
Overall, 26.6% (16/60 cases) carried pathogenic or likely pathogenic variants in a FTD-related gene, including: MAPT Gln351Arg (n = 1); GRN Cys92Ter (n = 1), Ser301Ter (n = 2), c.462 + 1G > C (n = 1); C9orf72 expansion (35-70 repeats; n = 8); TREM2 Arg47Cys (n = 1); and OPTN frameshift insertion (n = 2). Genetic mutations accounted for 48% (12/25) of patients with familial FTD, and 11.4% (4/35) of patients with sporadic FTD. C9orf72 repeat expansions were the most common genetic mutation (13.3%, 8/60), followed by GRN (6.7%, 4/60) variants. Within mutation carriers, plasma NfL was highest in a C9orf72 expansion carrier, and CSF NfL was highest in a GRN splice variant carrier.
In our cohort, genetic mutations are present in one-quarter of FTD-spectrum cases, and up to half of those with family history. Our findings highlight the importance of wider implementation of genetic testing in FTD patients from Southeast Asia.
额颞叶痴呆(FTD)包括一系列神经退行性疾病,包括行为变异型 FTD(bvFTD)、语义变异型原发性进行性失语症(svPPA)和非流利型进行性失语症(nfvPPA)。虽然 FTD 中存在强烈的遗传成分,但亚洲的遗传性 FTD 报道较少。我们旨在研究东南亚 FTD 患者携带已知遗传性 FTD 变异的频率。
共纳入来自新加坡和菲律宾的 60 名 FTD 谱系患者(25 名家族性和 35 名散发性)。所有患者均接受了下一代测序和重复引物 PCR 以检测 C9orf72 扩增。部分患者检测了神经丝轻链(NfL)水平。
总体而言,26.6%(60 例中有 16 例)携带与 FTD 相关基因的致病性或可能致病性变异,包括:MAPT Gln351Arg(n=1);GRN Cys92Ter(n=1)、Ser301Ter(n=2)、c.462+1G>C(n=1);C9orf72 扩增(35-70 个重复;n=8);TREM2 Arg47Cys(n=1);和 OPTN 移码插入(n=2)。遗传突变占家族性 FTD 患者的 48%(12/25),散发性 FTD 患者的 11.4%(4/35)。C9orf72 重复扩增是最常见的遗传突变(13.3%,8/60),其次是 GRN(6.7%,4/60)变异。在突变携带者中,C9orf72 扩增携带者的血浆 NfL 最高,GRN 剪接变异携带者的 CSF NfL 最高。
在我们的队列中,FTD 谱系病例中有四分之一存在遗传突变,且有家族史的患者中高达一半存在遗传突变。我们的发现强调了在东南亚 FTD 患者中广泛实施遗传检测的重要性。